Comparing chemical transfection, electroporation, and lentiviral vector transduction to achieve optimal transfection conditions in the Vero cell line
- PMID: 38741034
- PMCID: PMC11089686
- DOI: 10.1186/s12860-024-00511-x
Comparing chemical transfection, electroporation, and lentiviral vector transduction to achieve optimal transfection conditions in the Vero cell line
Abstract
Background: Transfection is an important analytical method for studying gene expression in the cellular environment. There are some barriers to efficient DNA transfection in host cells, including circumventing the plasma membrane, escaping endosomal compartmentalization, autophagy, immune sensing pathways, and translocating the nuclear envelope. Therefore, it would be very useful to introduce an optimum transfection approach to achieve a high transfection efficiency in the Vero cell line. The aim of this study was to compare various transfection techniques and introduce a highly efficient method for gene delivery in Vero cells.
Methods: In the current study, three transfection methods were used, including chemical transfection, electroporation, and lentiviral vector transduction, to obtain the optimum transfection conditions in the Vero cell line. Vero cells were cultured and transfected with chemical transfection reagents, electroporation, or HIV-1-based lentivectors under different experimental conditions. Transfection efficiency was assessed using flow cytometry and fluorescence microscopy to detect GFP-positive cells.
Results: Among the tested methods, TurboFect™ chemical transfection exhibited the highest efficiency. Optimal transfection conditions were achieved using 1 µg DNA and 4 µL TurboFect™ in 6 × 104 Vero cells.
Conclusion: TurboFect™, a cationic polymer transfection reagent, demonstrated superior transfection efficiency in Vero cells compared with electroporation and lentivirus particles, and is the optimal choice for chemical transfection in the Vero cell line.
Keywords: Chemical transfection reagents; Electroporation; Lentivirus; Transfection efficiency; TurboFect; Vero cell line.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures





Similar articles
-
Optimization of transfection methods for Huh-7 and Vero cells: comparative study.Tsitol Genet. 2012 Nov-Dec;46(6):19-27. Tsitol Genet. 2012. PMID: 23285746
-
Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.J Vis Exp. 2012 Apr 8;(62):e3171. doi: 10.3791/3171. J Vis Exp. 2012. PMID: 22508377 Free PMC article.
-
Production of lentiviral vectors for transducing cells from the central nervous system.J Vis Exp. 2012 May 24;(63):e4031. doi: 10.3791/4031. J Vis Exp. 2012. PMID: 22664962 Free PMC article.
-
[Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].Zhonghua Yi Xue Za Zhi. 2006 Dec 19;86(47):3340-4. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17313830 Chinese.
-
Optimization of transfection methods for Huh-7 and Vero cells: A comparative study.Cytol Genet. 2012;46(6):347-353. doi: 10.3103/S0095452712060035. Epub 2012 Dec 5. Cytol Genet. 2012. PMID: 32214542 Free PMC article.
Cited by
-
Bioelectric profiling of Rickettsia montanensis in Vero cells utilizing dielectrophoresis.J Biol Eng. 2025 Feb 18;19(1):18. doi: 10.1186/s13036-025-00487-y. J Biol Eng. 2025. PMID: 39966846 Free PMC article.
-
Advances in CRISPR-Cas9 in lineage tracing of model animals.Animal Model Exp Med. 2025 Jun;8(6):1004-1022. doi: 10.1002/ame2.70033. Epub 2025 Jun 10. Animal Model Exp Med. 2025. PMID: 40491322 Free PMC article. Review.
-
Transfection Technologies for Next-Generation Therapies.J Clin Med. 2025 Aug 5;14(15):5515. doi: 10.3390/jcm14155515. J Clin Med. 2025. PMID: 40807133 Free PMC article. Review.
References
-
- Ewunkem AJ, Agee K. Optimization of transfection methods for human lymphoblast TK6 cell line. Gene Protein Dis. 2023.
-
- Sène MA, Xia Y, Kamen AA. Overview of recent advances in Vero cells genomic characterization and engineering for high-throughput vaccine manufacturing. Clin Translational Discovery. 2022;2(2):e40. doi: 10.1002/ctd2.40. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials